US stock futures were practically flat on Monday as traders stayed on the sidelines awaiting for another batch of corporate earnings, including from tech behemoth Alphabet (GOOG, GOOGL).
Oil prices eased from earlier gains with global benchmark Brent crude down 0.16%, while US crude West Texas Intermediate was down 0.38% recently, but losses were capped by expectations of tightening supply following US sanctions against crisis-hit Venezuela.
At 10 am, data are expected to show factory orders rising 0.3% in November against the 2.1% drop in the previous month, according to data compiled by Econoday.
In equities, shares of BioLineRX ( BLRX ) were 32.6% higher pre-bell after the biopharmaceutical company said the US Food and Drug Administration has granted orphan drug designation to its lead oncology candidate BL-8040 for the treatment of pancreatic cancer.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
Go to Appearance > Customize > Subscribe Pop-up to set this up.
Wealth Empire Newsletter
Register now for free updates and alerts
Note: I have the ability to revoke this permission at any time and ask for the removal of my personal data collected by contacting us or simply clicking Unsubscribe.